Biosimilars Report Bolsters IGBA’s Calls To Streamline Development Process
IPRP Biosimilars Working Group Urges Reassessment Of Comparative Efficacy Studies
• By David Wallace
The IGBA wants a more streamlined approach to biosimilar development • Source: IGBA 
